Grzegorz Madej

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

K. Simon, A. Horban, E. Janczewska, 2016, Alimentary pharmacology & therapeutics.